Siyi Jiang

453 total citations · 1 hit paper
17 papers, 311 citations indexed

About

Siyi Jiang is a scholar working on Molecular Biology, Cancer Research and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Siyi Jiang has authored 17 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Siyi Jiang's work include Multiple Myeloma Research and Treatments (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Siyi Jiang is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Siyi Jiang collaborates with scholars based in China and United States. Siyi Jiang's co-authors include Yunzheng Liang, Su Chen, Liang Tian, Qing Li, Liangliang Zhu, Yunfeng Fu, Chengyuan Li, Jing Liu, Hang Dong and Yanwei Luo and has published in prestigious journals such as Chemical Society Reviews, Chemical Engineering Journal and Hypertension.

In The Last Decade

Siyi Jiang

15 papers receiving 303 citations

Hit Papers

Advances in photothermal regulation strategies: from effi... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siyi Jiang China 9 117 91 74 52 45 17 311
Sixu Liu China 12 144 1.2× 106 1.2× 52 0.7× 219 4.2× 25 0.6× 42 504
Zeyu Jiang China 12 96 0.8× 45 0.5× 26 0.4× 67 1.3× 31 0.7× 35 438
Qiuyu Liu China 9 65 0.6× 40 0.4× 83 1.1× 67 1.3× 11 0.2× 43 403
Kaili Zhao China 13 149 1.3× 26 0.3× 76 1.0× 175 3.4× 33 0.7× 25 437
Xin Shi China 9 69 0.6× 29 0.3× 68 0.9× 69 1.3× 5 0.1× 32 353
Junchao Yu China 12 59 0.5× 25 0.3× 57 0.8× 67 1.3× 12 0.3× 23 339
Zhangli Liu China 12 71 0.6× 83 0.9× 36 0.5× 77 1.5× 12 0.3× 38 474
Qijing Guo China 11 98 0.8× 56 0.6× 216 2.9× 14 0.3× 9 0.2× 26 391

Countries citing papers authored by Siyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Siyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siyi Jiang more than expected).

Fields of papers citing papers by Siyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siyi Jiang. The network helps show where Siyi Jiang may publish in the future.

Co-authorship network of co-authors of Siyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Siyi Jiang. A scholar is included among the top collaborators of Siyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siyi Jiang. Siyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
Jiang, Siyi, Lili Gao, Jian Li, et al.. (2024). N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair. Frontiers in Cell and Developmental Biology. 12. 1383232–1383232. 5 indexed citations
4.
Gu, Junchao, Siyi Jiang, Yujing Weng, et al.. (2024). Lignin carbon-initiated Ni/K/Mo2C catalyst for efficient synthesis of higher alcohols from syngas. Chemical Engineering Journal. 481. 148751–148751. 12 indexed citations
5.
Fu, Yunfeng, Jianfeng Sang, Fangrong Zhang, et al.. (2024). Exosomal tRF-1003 induces angiogenesis via regulating the HIF1α/VEGF signaling in multiple myeloma. International Immunopharmacology. 146. 113862–113862. 2 indexed citations
6.
Dong, Hang, et al.. (2024). Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth. Oncogenesis. 13(1). 2 indexed citations
7.
Liu, Bailin, Liang Xia, Yong Li, et al.. (2023). Prenatal Nicotine Exposure Raises Male Blood Pressure via FTO-Mediated NOX2/ROS Signaling. Hypertension. 81(2). 240–251. 8 indexed citations
8.
Zhu, Liangliang, Liang Tian, Siyi Jiang, et al.. (2023). Advances in photothermal regulation strategies: from efficient solar heating to daytime passive cooling. Chemical Society Reviews. 52(21). 7389–7460. 131 indexed citations breakdown →
9.
Yang, Qin, Siyi Jiang, Qiangqiang Zhao, et al.. (2023). CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma. International Journal of Pharmaceutics. 643. 123241–123241. 10 indexed citations
12.
Jiang, Siyi, et al.. (2023). Conversion of CO2 Hydrogenation to Methanol over K/Ni Promoted MoS2/MgO Catalyst. Catalysts. 13(7). 1030–1030. 6 indexed citations
13.
Xue, Xiaoxiao, Yujing Weng, Siyi Jiang, et al.. (2022). Synthesis and characterization of molybdenum carbide catalysts on different carbon supports. Catalysis Today. 402. 266–275. 16 indexed citations
14.
Gao, Meng, Chengyuan Li, Han Xiao, et al.. (2019). hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma. Frontiers in Oncology. 9. 1261–1261. 46 indexed citations
15.
Jiang, Siyi, et al.. (2019). <p>Evodiamine Selectively Inhibits Multiple Myeloma Cell Growth by Triggering Activation of Intrinsic Apoptosis Pathway</p>. OncoTargets and Therapy. Volume 12. 11383–11391. 13 indexed citations
16.
17.
Dong, Hang, Siyi Jiang, Yunfeng Fu, et al.. (2019). Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma. Frontiers in Pharmacology. 10. 45–45. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026